Profil de l'hépatite C et de l'utilisation de drogues injectables au Canada

Bibliographie

Adlaf, E.M., Zdanowicz, Y.M. & Smart, R.G. (1996). Alcool and other drug use among street-involved youth in Toronto. Addiction Research Foundation, 4, 11-24.

Anderson, J. (1993). A Study of Out-of-the-Mainstream Youth in Halifax, Nova Scotia. Ottawa: Minister of Supply and Services.

Archibald, C., Ofner, M., Patrick, D. et al. (1996). A study of risk factors for HIV infection among Vancouver's injection drug using community: Summary of final results. Unpublished Report. Vancouver: The Point Project.

Baozhang, T., Kaining, Z., Jinxing, K. et al. (1997). Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts. Epidemiol. Infect., 119, 343-347.

Bardsley, J., Turvey, J. & Blatherwick, J. (1990). Vancouver's needle exchange program. Canadian Journal of Public Health, 81, 39-45.

Barnard, M. (1993). Needle sharing in context: patterns of sharing among men and women injectors and HIV risks. Addiction, 88, 805-812.

B.C. Aboriginal HIV/AIDS Task Force (1999). The Red Road - Pathways to Wholeness.

Belanger, D., Alary, M., Godin, G. et al. (1996). Identification of Sub-groups at High Risk of Sharing Used Needles among Injection Drug Users Participating in a Needle-exchange Program. University of Laval: unpublished paper.

Bruneau, J. (1994). Prevalence, incidence and risk factors of HIV for drug addiction using injectable drugs. In Second National Workshop on HIV, Alcohol and Other Drug Use: Proceedings. Ottawa, Canadian Centre on Substance Abuse, 48-51.

Bruneau, J., Lamothe, F., Franco, E. et al. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology, 146, 994-1002.

Butler, T.G., Dolan, K.A., Ferson, M.J. et al. (1997). Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. Medical Journal of Australia, 166,
127-130.

Calzavara, L.M., Myers, T., Millson, M. et al. (1997). Understanding HIV-related Risk Behaviour in Prisons: The Inmates' Perspective.

Canadian Blood Services (1999). Nucleic Acid Amplification Testing for Hepatitis C. Scientific Paper. http://www.bloodservices.ca/CentreApps/Internet/
UW_V502_MainEngine.nsf/9749ca80b75a038585256aa20060
d703/708f54b29790a54585256abe0050069d?OpenDocument
Canadian Centre for Drug-Free Sport (CCDFS) (1993). National School Survey of Drugs and Sport - Final Report. Ottawa: CCDFS.

Canadian HIV/AIDS Legal Network (1999). HIV/AIDS and Hepatitis C in Prisons: The Facts. Fact Sheet. Health Canada.

Canadian Liver Foundation (1999). Facts about Hepatitis C. Health Canada.

Carruthers, S. & Loxley, W. (1995). Hepatitis C and young drug users: Are they about to join the epidemic? Australian Journal of Public Health, 19, 421-424.

Cattaneo, C., Nuttall, P.A., and Sokol, R.J. (1996). Detection of HIV, hepatitis B and hepatitis C markers in discarded syringes and bloodstains. Science, 36, 271-274.

Centre for Disease Cont rol (CDC) (1998). Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease. www.cdc.gov.

Chang, C.J., Lin, C.H., Lee, C.T. et al. (1999). Hepatitis C virus infection among shortterm intravenous drug users in southern Taiwan. European Journal of Epidemiology, 15 , 597-601.

Choo, Q.L., Kuo, G., Wiener, A.J. et al. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244, 359-362.

Coates, R., Rankin, J., Lamothe, F. et al. (1992). Needle sharing behaviour among injection drug users in treatment in Montreal and Toronto, 1988-89. Canadian Journal of Public Health, 83 , 38-41.

Copeland, J.; Howard, J.; and Fleischamann, S. (1998). Gender, HIV knowledge and risktaking behaviour among substance using adolescents in custody in New South Wales. Journal of Substance Misuse, 3, 206-212.

Covenant House (1988). Information Brochure. Toronto: Covenant House.

Crofts, N., Hopper, J.L., Bowden, D.S. et al. (1993). Hepatitis C virus infection among a cohort of Victorian injecting drug users. Medical Journal of Australia, 159, 237-241.

Crofts, N., Stewart, T., Hearne, P. et al. (1995). Spread of bloodborne viruses among Australian prison entrants. British Medical Journal, 310, 285-288.

Crofts, N. & Aitken, C.K. (1997). Incidence of bloodborne virus infection and risk in a cohort of injecting drug users in Victoria, 1990-1995. Medical Journal of Australia, 167, 17-20.

Crofts, N., Jolley, D. Kaldor, J. et al. (1997). Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health, 51, 692-697.

Crofts, N., Aitken, C.K., Kaldor, J.M. (1999). The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia, 170, 220-221.

Devellaer, M. & Smye, V. (1994). Understanding Injection Drug Users: The First Step in Planning Needle Exchange Programs . Hamilton: Addiction Research Foundation.

Dienstag, J. (1997). Sexual and Perinatal Spread of Hepatitis C Virus Infection. National Institute of Health Conference on Hepatitis C, March 24-26, Bethesda, Maryland. www.hepnet.com.

Elinitsky, S. & Abernathy, T. (1993). Calgary's needle exchange program: profile of injection drug users. Canadian Journal of Public Health, 84, 177-180.

Finch, E. (1998). HCV policies - where do we go? International Journal of Drug Policy, 9, 1-2.

Fischer, B. (1998). Prescriptions, Power and Politics: The Turbulent History of Methadone Maintenance in Canada. Toronto: Centre for Addiction and Mental Health.

Fisher, D. G., Fenaughty, A.M., Paschane, A.A. et al. (1997). Hepatitis C virus infection among Alaskan drug users. American Journal of Public Health, 87, 1722-1724.

Garfein, R.S., Vlahov, D., Galai, N. et al. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency and human T-lymphotropic viruses. American Journal of Public Health, 86 , 655-661.

Garfein, R.S., Doherty, M.C., Monterroso, E.R. et al. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S11-S19.

Gilbert, L., El-Bassel, N., Schilling, R. et al. (1997). Childhood abuse as a risk for partner abuse among women in methadone aintenance. American Journal of Drug and Alcohol Abuse, 23, 581-595.

Hagan, J. & McCarthy, B. (1997). Mean Streets: Youth Crime and Homelessness. Cambridge: Cambridge University Press.

Heintges, T. & Wands, J.R. (1997). Hepatitis C virus: Epidemiology and transmission. Hepatology, 26, 521-526.

Hewitt, D. & Vinje, G. (1991). Injection drug use among addictions treatment clients in Alberta: Implications for the spread of AIDS. Canadian Journal of Public Health, 82, 205-207.

Huebert, K. & James, D. (1992). High-risk behaviours for transmission of HIV among clients in treatment for substance abuse. Journal of Drug Issues, 22, 885-901.

James, D. & Huebert, K. (1991). HIV Risk Behaviours among Clients. Edmonton: Alberta Alcohol and Drug Abuse Commission.

Jurgens, R. (1996). HIV/AIDS in Prisons: Final Report. Ottawa: Canadian AIDS Society.

Kemp, R., Miller, J., Lungley, S. et al. (1998). Injecting behavio urs and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. New Zealand Medical Journal, 111, 50-53.

Laboratory Centre for Disease Control (LCDC) (1999). Hepatitis C Prevention and Control: A Public Health Consensus. The Canadian Communicable Diseases Report, 25 (suppl. 1) 1-25.

Liddle, C. (1996). Hepatitis C. Anaesthesia and Intensive Care, 24, 180-183.

Lior, L. & Stratton, E. (1998). Seroprevalence of HIV, Hepatitis B and Hepatitis C viruses and high risk behaviours among IDU and sexual partners of IDU, October 1996- February 1997. Halifax: Nova Scotia Department of Health.

Lior, L.Y., Beal, J., Portman, J. et al. (1998). A Look Behind Closed Doors: Injection and Sexual Risk Behaviour and HIV, HBV and HCV Inside a Canadian Prison. Presentation at the World AIDS Conference, Geneva.

Marte, C. & Gatell, J.M. (1999). HIV-AIDS Policy Issues Related to Care, Treatment and Support of IDU Communities. Dialogue on HIV/AIDS: Policy Dilemmas Facing Governments.

Massad, E., Rozman, M., Azevedo, R.S. et al. (1999). Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: Preponderance of parenteral transmission. European Journal of Epidemiology, 15, 439-445.

Mather, D. & Crofts, N. (1999). A computer model of the spread of hepatitis C virus among injecting drug users. European Journal of Epidemiology, 15, 5-10.

McAmmond and Associates (1997). Care, Treatment and Support for Injection Drug Users Living with HIV/AIDS. Report prepared for Health Canada.

McCreary Centre Soceity (1994). Adolescent Health Survey: Youth and AIDS in British Columbia. Detailed Analysis of the Adolescent Health Survey Data Related to Youth and AIDS in British Columbia. Vancouver.

Medical Research Council of Canada (MRC) (1999). Identification of a Research Agenda for the Diagnosis, Care and Prevention of Hepatitis C in Canada. Report to the Minister of Health.

Millar, J. (1998). Hepatitis and injection drug use in British Columbia - Pay now or Pay Later. Vancouver: B.C. Ministry of Health.

Millson, M., Coates, R., Devenyi, R. et al. (1990). AIDS-related knowledge, attitudes and behaviour in injections drug users attending a Toronto treatment facility. Canadian Journal of Public Health, 81 , 46-52.

Millson, P., Myers, T., Rankin, J. et al. (1995). Prevalence of Human Immunodeficiency Virus and associated risk factors in injection drug users in Toronto. Canadian Journal of Public Health, 86 , 176-180.

Myers, T., Millson, M., Rigby, J.M. et al. (1994). Biographical characteristics of injection drug users and behavioral predispositions related to HIV prevention and drug use.
Canadian Journal of Public Health, 85, 264-268.

Myers, T., Millson, M., Rigby, J. et al. (1995). A comparison of the determinants of safe injection and condom use among injecting dr ug users. Addiction, 90 , 217-226.

Ogilvie, E.L., Veit, F., Crofts, N. et al. (1999). Hepatitis infection among adolescents resident in Melbourne juvenile justice centre: Risk factors and challenges. Journal of Adolescent Health, 25, 46-51.

Oliveira, M., Bastos, F., Telles, P. et al. (1999). Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Brazilian Journal of Medical and Biological Research, 32 , 1107-1114.

Pallas, J.R., Farinas -Alvarex, C., Prieto, D. et al, (1999). Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. European Journal of Epidemiology, 15, 699-704.

Patrick, D.M., Cornelisse, P.G., Sherlock, C.H. et al. (1998). Hepatitis C prevalence and incidence in Vancouver IDUs during an outbreak of HIV infection. International Conference on AIDS, 12, 145.

Patrick, D.M., Buxton, J.A., Bigham, M. et al. (2000). Public Health and Hepatitis C. Vancouver: UBC Centre for Disease Control.

Poulin, C., Gyorkos, T., Joseph, L. et al. (1992). An epidemic of hepatitis B among injection drug users in a rural area. Canadian Journal of Public Health, 83, 102-105.

Poulin, C., Alary, M., Noel, L. et al. (1995). HIV infection and risk factors among injection drug users attending a needle exchange program in Quebec City. Quebec: Unpublished report.

Radford, J.L., King, A.J.C., Warren, W.K. (1989). Street Youth and AIDS. Kingston: Health and Welfare Canada.

Reindollar, R.W. (1999). Hepatitis C and the correctional population. American Journal of Medicine, 107, 100S-103S.

Remis, R., Millson, M.,& Major, C. (1997). The HIV Epidemic among Injection Drug Users in Ontario: The Situation in 1997. Toronto: AIDS Bureau, Ministry of Health.

Remis, R. (1998). Estimating the number of blood transfusion recipients infected by hepatitis C in Canada 1960-85 and 1990-92. Health Canada.

Riehman, K. (1996). Injecting Drug Use and AIDS in Developing Countries: Determinants and Issues for Policy Consideration. Background paper for the Policy Research Report Confronting AIDS. World Bank, Policy Research Department. www.worldbank.org.

Romanowski, B., Campbell, R.J., Preiksaitis, J. et al. (1997). Human Immunodeficiency Virus seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics in Alberta. Sexually Transmitted Diseases, 24, 487-494.

Rothon, D., Strathdee, S., Cook, D. et al. (1997). Determinants of HIV-related high risk behaviours among young offenders: A window of opportunity. Canadian Journal of Public Health, 88, 14-17.

Roy, D. & Cloutier, R. (1994). Drug Use and the HIV Epidemic: A Framework for Prevention. Quebec: Ministry of Health and Social Services.

Roy, E., Haley, N., Boivin, J.F. et al. (1996). HIV Infection Among Montreal Street Youth. Montreal: Groupe de recherche sur les jeunes del al rue et l'infection au VIH.

Roy, E., Lemire, N., Haley, N. et al. (1998). Injection drug use among street youth: A dynamic process. Canadian Journal of Public Health, 89, 23-25.

Saskatchewan Alcohol and Drug Abuse Commission (SADAC) (1993). SADAC client profile 1991/92: Injection drug users in treatment. Focus Sheet. Regina, SADAC.

Scott, K. (1997). Indigenous Canadians. In D. McKenzie, R. Williams & E. Single (Eds.) Canadian Profile: Alcohol, Tobacco and Other Drugs, 1997. Ottawa: Canadian Centre on Substance Abuse, 133-164.

Scully, L.J., Mitchell, S. & Gill, P. (1993). Clinical and epidemiologic characteristics of hepatitis C in a gastroenterology/hepatology practice in Ottawa. Canadian Medical Association Journal, 148, 1173-1177.

Shields, S. (2000). Enhanced Surveillance of Canadian Street Youth - Phase II Self Identified Aboriginal Youth. Division of STD Prevention and Control. Bureau of HIV/AIDS, STD & TB.

Silverman, A., Sekhon, J., Saginaw, S. et al. (2000). Tattoo application is not associated with an increased risk for chronic viral hepatitis. American Journal of Gastroenerology, 95, 1312-1315.

Single, E. (2000). A Socio-demographic Profile of Drug Users in Canada. HIV/AIDS Prevention and Community Action Programs of Health Canada.

Sladden, T.J., Hickey, A.R., Dunn, T.M. et al. (1997). Hepatitis C transmission on the north coast of New South Wales: Explaining the unexplained. Medical Journal of Australia, 166, 290-293.

Smart, R.G., Adlaf, E.M., Porterfield, K.M. et al. (1990) Drugs, Youth and the Street. Addiction Research Foundation.

Smart, R.G., Adlaf, E.M., Walsh, G.W. et al. (1992). Drifting and Doing: Changes in Drug Use Among Toronto Street Youth, 1990-1992. Toronto: Addiction Research Foundation.

Smart, R.G. & Adlaf, E.M. (1991). Substance use and problems among Toronto street youth. British Journal of Addiction, 86, 999-1010.

Smyth, B.P., Keenan, E. & O'Connor, J.J. (1999). Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among shortterm injecting drug users. Journal of Epidemiology Community Health, 53, 434-435.

Strathdee, S., Patrick, D. Currie, S. et al. (1997). Needle exchange is not enough: Lessons from Vancouver injecting drug use study. AIDS, 11, F59-F65.

Stratton, E., Lior, L., Gully, P. et al. (1997). HIV, HBV and HCV and risk behaviours in a semi-rural community in Canada. Unpublished paper. Halifax: Nova Scotia Department of Health.

Sweet, L., Van Til, L., Abbott, L. (1996). Voluntary Anonymous HIV Survey of PEI Addiction Treatment Facility Patients. Charlottetown: Prince Edward Island Department of Health.

Thomas, D.J., Vlahov, D., Solomon, L. et al. (1995). Correlates of hepatitis C virus infections among injection drug users. Medicine, 74, 212-220.

Topp, J. (1994). HIV infection prevention measures for drug users. In Second National Workshop on HIV, Alcohol and Other Drug Use: Proceedings. Ottawa: Canadian Centre on Substance Abuse, 26-29.

Toronto Department of Public Health (TDPH) (1994). Needle Exchange Statistics. Cited in Devillaer, M. Smye. V. Understanding Injection Drug Users: The First Step in Planning Needle Exchange Programs . Hamilton: Addiction Research Foundation.

Tranchina, J. (1998). Hepatitis C epidemic. Harm Reduction Communication, 22-23.

Van Beek, I., Dwyer, R., Dore, G.J. et al. (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. British Medical Journal, 17, 433-437.

Villano, S.A., Vlahov, D., Nelson, K.E. et al. (1997). Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology, 35, 3274-3277.

Whynot, E. (1998). Women who use injection drugs: The social context of risk. Canadian Medical Association Journal, 159, 355-358.

Winnipeg Injection Drug Epidemiology Study (WIDE) (1999). A Study of the Epidemiology of Injection Drug Use and HIV Infection Winnipeg, Manitoba. Manitoba Health.

Wodak, A. (1997). Hepatitis C: Waiting for the grim reaper. Medical Journal of Australia, 166, 284-285.

Wolfe, R. & Sykes, B. (1992). Needleworks: Prevention of HIV in Injection Drug Users: Final Report and Evaluation. Edmonton: Board of Health.

Zanetti, A.R., Tanzi, E., Paccagnini, S. et al. (1995). Mother-to-infant transmission of hepatitis C virus. Lancet, 345, 289-291.

Zanetti, A.R., Tanzi, E., Newell, M.L. (1999). Mother-to-infant transmission of hepatitis C virus. Journal of Hematology, 31, 96-100.

Zou, S., Zhang, J., Tepper, M. et coll. (2000).Enhanced Surveillance of Acute Hepatitis B and C. Canadian Journal of Infectious Disease (sous presse).

Précédent